Review Article

呼出气冷凝物的代谢组学:核磁共振波谱和质谱:方法论

卷 27, 期 14, 2020

页: [2381 - 2399] 页: 19

弟呕挨: 10.2174/0929867325666181008122749

价格: $65

摘要

呼吸系统疾病在普通人群中的流行率很高,全世界的发病率,死亡率和医疗保健费用也在增加。它们是复杂且异质的病理,可能在不同主题中呈现出不同的病理方面,通常 随着个人发展。因此,需要鉴定具有相似特征,预后或治疗的患者,以定义所谓的表型,而且还需要标记每种表型内的特定差异,以定义内表型。 生物标志物对于研究呼吸表型和内型非常有用。代谢组学是最近引入的“组学”之一,正在成为生物标记物发现的领先技术。对于呼吸道,代谢组学似乎非常适合,因为呼吸道提供了一种天然基质,即呼出气冷凝物(EBC),可以在其中测量多种生物标志物。在这篇综述中,我们将讨论与核磁共振(NMR)谱和质谱(MS)在EBC代谢组学中研究呼吸系统疾病有关的主要方法学问题。

关键词: 气道疾病,呼出气冷凝物,肺,康复,质谱,代谢组学,NMR光谱。

« Previous
[1]
Agusti, A.; Sobradillo, P.; Celli, B. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. Am. J. Respir. Crit. Care Med., 2011, 183(9), 1129-1137.
[http://dx.doi.org/10.1164/rccm.201009-1414PP] [PMID: 21169466]
[2]
van Mastrigt, E.; de Jongste, J.C.; Pijnenburg, M.W. The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children - clinical tools or scientific toys? Clin. Exp. Allergy, 2015, 45(7), 1170-1188.
[http://dx.doi.org/10.1111/cea.12454] [PMID: 25394891]
[3]
Maniscalco, M.; Motta, A. Metabolomics of exhaled breath condensate: a means for phenotyping respiratory diseases? Biomarkers Med., 2017, 11(6), 405-407.
[http://dx.doi.org/10.2217/bmm-2017-0068] [PMID: 28617073]
[4]
Mastrangelo, A.; Barbas, C. Chronic diseases and lifestyle biomarkers identification by metabolomics. Adv. Exp. Med. Biol., 2017, 965, 235-263.
[http://dx.doi.org/10.1007/978-3-319-47656-8_10] [PMID: 28132183]
[5]
Urbanczyk-Wochniak, E.; Luedemann, A.; Kopka, J.; Selbig, J.; Roessner-Tunali, U.; Willmitzer, L.; Fernie, A.R. Parallel analysis of transcript and metabolic profiles: a new approach in systems biology. EMBO Rep., 2003, 4(10), 989-993.
[http://dx.doi.org/10.1038/sj.embor.embor944] [PMID: 12973302]
[6]
Sauer, U.; Heinemann, M.; Zamboni, N. Genetics. Getting closer to the whole picture. Science, 2007, 316(5824), 550-551.
[http://dx.doi.org/10.1126/science.1142502] [PMID: 17463274]
[7]
Horváth, I.; Hunt, J.; Barnes, P.J.; Alving, K.; Antczak, A.; Baraldi, E.; Becher, G.; van Beurden, W.J.; Corradi, M.; Dekhuijzen, R.; Dweik, R.A.; Dwyer, T.; Effros, R.; Erzurum, S.; Gaston, B.; Gessner, C.; Greening, A.; Ho, L.P.; Hohlfeld, J.; Jöbsis, Q.; Laskowski, D.; Loukides, S.; Marlin, D.; Montuschi, P.; Olin, A.C.; Redington, A.E.; Reinhold, P.; van Rensen, E.L.; Rubinstein, I.; Silkoff, P.; Toren, K.; Vass, G.; Vogelberg, C.; Wirtz, H. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur. Respir. J., 2005, 26(3), 523-548.
[http://dx.doi.org/10.1183/09031936.05.00029705] [PMID: 16135737]
[8]
Sofia, M.; Maniscalco, M.; de Laurentiis, G.; Paris, D.; Melck, D.; Motta, A. Exploring airway diseases by NMR-based metabonomics: a review of application to exhaled breath condensate. J. Biomed. Biotechnol., 2011, 2011403260
[http://dx.doi.org/10.1155/2011/403260] [PMID: 21437214]
[9]
Horváth, I.; Barnes, P.J.; Loukides, S.; Sterk, P.J.; Högman, M.; Olin, A.C.; Amann, A.; Antus, B.; Baraldi, E.; Bikov, A.; Boots, A.W.; Bos, L.D.; Brinkman, P.; Bucca, C.; Carpagnano, G.E.; Corradi, M.; Cristescu, S.; de Jongste, J.C.; Dinh-Xuan, A.T.; Dompeling, E.; Fens, N.; Fowler, S.; Hohlfeld, J.M.; Holz, O.; Jöbsis, Q.; Van De Kant, K.; Knobel, H.H.; Kostikas, K.; Lehtimäki, L.; Lundberg, J.; Montuschi, P.; Van Muylem, A.; Pennazza, G.; Reinhold, P.; Ricciardolo, F.L.M.; Rosias, P.; Santonico, M.; van der Schee, M.P.; van Schooten, F.J.; Spanevello, A.; Tonia, T.; Vink, T.J. A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur. Respir. J., 2017, 49(4), 49.
[http://dx.doi.org/10.1183/13993003.00965-2016] [PMID: 28446552]
[10]
Accordino, R.; Visentin, A.; Bordin, A.; Ferrazzoni, S.; Marian, E.; Rizzato, F.; Canova, C.; Venturini, R.; Maestrelli, P. Long-term repeatability of exhaled breath condensate pH in asthma. Respir. Med., 2008, 102(3), 377-381.
[http://dx.doi.org/10.1016/j.rmed.2007.10.014] [PMID: 18061423]
[11]
Davis, M.D.; Montpetit, A.J. Exhaled Breath Condensate: An Update. Immunol. Allergy Clin. North Am., 2018, 38(4), 667-678.
[http://dx.doi.org/10.1016/j.iac.2018.06.002] [PMID: 30342587]
[12]
Ahmadzai, H.; Huang, S.; Hettiarachchi, R.; Lin, J.L.; Thomas, P.S.; Zhang, Q. Exhaled breath condensate: a comprehensive update. Clin. Chem. Lab. Med., 2013, 51(7), 1343-1361.
[http://dx.doi.org/10.1515/cclm-2012-0593] [PMID: 23420285]
[13]
Rosias, P. Methodological aspects of exhaled breath condensate collection and analysis. J. Breath Res., 2012, 6(2)027102
[http://dx.doi.org/10.1088/1752-7155/6/2/027102] [PMID: 22522968]
[14]
de Laurentiis, G.; Paris, D.; Melck, D.; Maniscalco, M.; Marsico, S.; Corso, G.; Motta, A.; Sofia, M. Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. Eur. Respir. J., 2008, 32(5), 1175-1183.
[http://dx.doi.org/10.1183/09031936.00072408] [PMID: 18653649]
[15]
Bell, J.D.; Brown, J.C.; Sadler, P.J. NMR studies of body fluids. NMR Biomed., 1989, 2(5-6), 246-256.
[http://dx.doi.org/10.1002/nbm.1940020513] [PMID: 2701808]
[16]
Gaber, F.; Acevedo, F.; Delin, I.; Sundblad, B.M.; Palmberg, L.; Larsson, K.; Kumlin, M.; Dahlén, S.E. Saliva is one likely source of leukotriene B4 in exhaled breath condensate. Eur. Respir. J., 2006, 28(6), 1229-1235.
[http://dx.doi.org/10.1183/09031936.00151905] [PMID: 16971403]
[17]
Motta, A.; Paris, D.; D’Amato, M.; Melck, D.; Calabrese, C.; Vitale, C.; Stanziola, A.A.; Corso, G.; Sofia, M.; Maniscalco, M. NMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperatures. J. Proteome Res., 2014, 13(12), 6107-6120.
[http://dx.doi.org/10.1021/pr5010407] [PMID: 25393672]
[18]
Nicholson, J.K.; Lindon, J.C. Systems biology: Metabonomics. Nature, 2008, 455(7216), 1054-1056.
[http://dx.doi.org/10.1038/4551054a] [PMID: 18948945]
[19]
Kaiser, K.A.M.C.; Fang, F.; Larive, C.K. Metabolic profiling In: NMR spectroscopy in pharmaceutical analysis, 2010, 233-267.
[20]
Nguyen, B.D.; Meng, X.; Donovan, K.J.; Shaka, A.J. SOGGY: solvent-optimized double gradient spectroscopy for water suppression. A comparison with some existing techniques. J. Magn. Reson., 2007, 184(2), 263-274.
[http://dx.doi.org/10.1016/j.jmr.2006.10.014] [PMID: 17126049]
[21]
Araníbar, N.; Ott, K.H.; Roongta, V.; Mueller, L. Metabolomic analysis using optimized NMR and statistical methods. Anal. Biochem., 2006, 355(1), 62-70.
[http://dx.doi.org/10.1016/j.ab.2006.04.014] [PMID: 16762305]
[22]
Palmer Iii, A.G.; Cavanagh, J.; Wright, P.E.; Rance, M. Sensitivity improvement in proton-detected two-dimensional heteronuclear correlation NMR spectroscopy. J. Magn. Reson., 1969, 1991(93), 151-170.
[23]
Beltran, A.; Suarez, M.; Rodríguez, M.A.; Vinaixa, M.; Samino, S.; Arola, L.; Correig, X.; Yanes, O. Assessment of compatibility between extraction methods for NMR- and LC/MS-based metabolomics. Anal. Chem., 2012, 84(14), 5838-5844.
[http://dx.doi.org/10.1021/ac3005567] [PMID: 22697410]
[24]
Bhardwaj, C.; Hanley, L. Ion sources for mass spectrometric identification and imaging of molecular species. Nat. Prod. Rep., 2014, 31(6), 756-767.
[http://dx.doi.org/10.1039/C3NP70094A] [PMID: 24473154]
[25]
Nadler, W.M.; Waidelich, D.; Kerner, A.; Hanke, S.; Berg, R.; Trumpp, A.; Rösli, C. MALDI versus ESI: The impact of the ion source on peptide identification. J. Proteome Res., 2017, 16(3), 1207-1215.
[http://dx.doi.org/10.1021/acs.jproteome.6b00805] [PMID: 28176526]
[26]
Fernández-Peralbo, M.A.; Calderón Santiago, M.; Priego-Capote, F.; Luque de Castro, M.D. Study of exhaled breath condensate sample preparation for metabolomics analysis by LC-MS/MS in high resolution mode. Talanta, 2015, 144, 1360-1369.
[http://dx.doi.org/10.1016/j.talanta.2015.08.010] [PMID: 26452970]
[27]
Effros, R.M.; Dunning, M.B., III; Biller, J.; Shaker, R. The promise and perils of exhaled breath condensates. Am. J. Physiol. Lung Cell. Mol. Physiol., 2004, 287(6), L1073-L1080.
[http://dx.doi.org/10.1152/ajplung.00069.2004] [PMID: 15531756]
[28]
Gessner, C.; Kuhn, H.; Seyfarth, H.J.; Pankau, H.; Winkler, J.; Schauer, J.; Wirtz, H. Factors influencing breath condensate volume. Pneumologie, 2001, 55(9), 414-419.
[http://dx.doi.org/10.1055/s-2001-16947] [PMID: 11536064]
[29]
Dwyer, T.M. Sampling airway surface liquid: non-volatiles in the exhaled breath condensate. Lung, 2004, 182(4), 241-250.
[http://dx.doi.org/10.1007/s00408-004-2506-3] [PMID: 15636196]
[30]
Baker, E.H.; Clark, N.; Brennan, A.L.; Fisher, D.A.; Gyi, K.M.; Hodson, M.E.; Philips, B.J.; Baines, D.L.; Wood, D.M. Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis. J. Appl. Physiol., 2007, 102(5), 1969-1975.
[http://dx.doi.org/10.1152/japplphysiol.01425.2006] [PMID: 17303703]
[31]
Peralbo-Molina, A.; Calderón-Santiago, M.; Priego-Capote, F.; Jurado-Gámez, B.; Luque de Castro, M.D. Development of a method for metabolomic analysis of human exhaled breath condensate by gas chromatography-mass spectrometry in high resolution mode. Anal. Chim. Acta, 2015, 887, 118-126.
[http://dx.doi.org/10.1016/j.aca.2015.07.008] [PMID: 26320793]
[32]
Nizio, K.D.; Perrault, K.A.; Troobnikoff, A.N.; Ueland, M.; Shoma, S.; Iredell, J.R.; Middleton, P.G.; Forbes, S.L. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study. J. Breath Res., 2016, 10(2)026008
[http://dx.doi.org/10.1088/1752-7155/10/2/026008] [PMID: 27120170]
[33]
Martin, A.N.; Farquar, G.R.; Jones, A.D.; Frank, M. Human breath analysis: methods for sample collection and reduction of localized background effects. Anal. Bioanal. Chem., 2010, 396(2), 739-750.
[http://dx.doi.org/10.1007/s00216-009-3217-7] [PMID: 19844696]
[34]
Vas, G.; Vékey, K. Solid-phase microextraction: a powerful sample preparation tool prior to mass spectrometric analysis. J. Mass Spectrom., 2004, 39(3), 233-254.
[http://dx.doi.org/10.1002/jms.606] [PMID: 15039931]
[35]
Amorim, L.C.; de L Cardeal, Z. Breath air analysis and its use as a biomarker in biological monitoring of occupational and environmental exposure to chemical agents. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2007, 853(1-2), 1-9.
[http://dx.doi.org/10.1016/j.jchromb.2007.03.023] [PMID: 17418649]
[36]
Aksenov, A.A.; Zamuruyev, K.O.; Pasamontes, A.; Brown, J.F.; Schivo, M.; Foutouhi, S.; Weimer, B.C.; Kenyon, N.J.; Davis, C.E. Analytical methodologies for broad metabolite coverage of exhaled breath condensate. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2017, 1061-1062, 17-25.
[http://dx.doi.org/10.1016/j.jchromb.2017.06.038] [PMID: 28697414]
[37]
Pauling, L.; Robinson, A.B.; Teranishi, R.; Cary, P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc. Natl. Acad. Sci. USA, 1971, 68(10), 2374-2376.
[http://dx.doi.org/10.1073/pnas.68.10.2374] [PMID: 5289873]
[38]
Phillips, M.; Gleeson, K.; Hughes, J.M.; Greenberg, J.; Cataneo, R.N.; Baker, L.; McVay, W.P. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet, 1999, 353(9168), 1930-1933.
[http://dx.doi.org/10.1016/S0140-6736(98)07552-7] [PMID: 10371572]
[39]
Prado, C.; Marín, P.; Periago, J.F. Application of solid-phase microextraction and gas chromatography-mass spectrometry to the determination of volatile organic compounds in end-exhaled breath samples. J. Chromatogr. A, 2003, 1011(1-2), 125-134.
[http://dx.doi.org/10.1016/S0021-9673(03)01103-8] [PMID: 14518769]
[40]
Pleil, J.D.; Hubbard, H.F.; Sobus, J.R.; Sawyer, K.; Madden, M.C. Volatile polar metabolites in exhaled breath condensate (EBC): collection and analysis. J. Breath Res., 2008, 2(2)026001
[http://dx.doi.org/10.1088/1752-7155/2/2/026001] [PMID: 21383442]
[41]
Bean, H.D.; Dimandja, J.M.; Hill, J.E. Bacterial volatile discovery using solid phase microextraction and comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2012, 901, 41-46.
[http://dx.doi.org/10.1016/j.jchromb.2012.05.038] [PMID: 22727751]
[42]
Mansoor, J.K.; Schelegle, E.S.; Davis, C.E.; Walby, W.F.; Zhao, W.; Aksenov, A.A.; Pasamontes, A.; Figueroa, J.; Allen, R. Analysis of volatile compounds in exhaled breath condensate in patients with severe pulmonary arterial hypertension. PLoS One, 2014, 9(4)e95331
[http://dx.doi.org/10.1371/journal.pone.0095331] [PMID: 24748102]
[43]
Figueroa, J.A.; Mansoor, J.K.; Allen, R.P.; Davis, C.E.; Walby, W.F.; Aksenov, A.A.; Zhao, W.; Lewis, W.R.; Schelegle, E.S. Exhaled volatile organic compounds in individuals with a history of high altitude pulmonary edema and varying hypoxia-induced responses. J. Breath Res., 2015, 9(2)026004
[http://dx.doi.org/10.1088/1752-7155/9/2/026004] [PMID: 25891856]
[44]
Devillier, P.; Salvator, H.; Naline, E.; Couderc, L.J.; Grassin-Delyle, S. Metabolomics in the diagnosis and pharmacotherapy of lung diseases. Curr. Pharm. Des., 2017, 23(14), 2050-2059.
[http://dx.doi.org/10.2174/1381612823666170130155627] [PMID: 28137216]
[45]
Phillips, M.; Herrera, J.; Krishnan, S.; Zain, M.; Greenberg, J.; Cataneo, R.N. Variation in volatile organic compounds in the breath of normal humans. J. Chromatogr. B Biomed. Sci. Appl., 1999, 729(1-2), 75-88.
[http://dx.doi.org/10.1016/S0378-4347(99)00127-9] [PMID: 10410929]
[46]
Hubbard, H.F.; Sobus, J.R.; Pleil, J.D.; Madden, M.C.; Tabucchi, S. Application of novel method to measure endogenous VOCs in exhaled breath condensate before and after exposure to diesel exhaust. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2009, 877(29), 3652-3658.
[http://dx.doi.org/10.1016/j.jchromb.2009.09.008] [PMID: 19797001]
[47]
Peralbo-Molina, A.; Calderón-Santiago, M.; Priego-Capote, F.; Jurado-Gámez, B.; Luque de Castro, M.D. Metabolomics analysis of exhaled breath condensate for discrimination between lung cancer patients and risk factor individuals. J. Breath Res., 2016, 10(1)016011
[http://dx.doi.org/10.1088/1752-7155/10/1/016011] [PMID: 26866403]
[48]
Cáp, P.; Chládek, J.; Pehal, F.; Malý, M.; Petrů, V.; Barnes, P.J.; Montuschi, P. Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients. Thorax, 2004, 59(6), 465-470.
[http://dx.doi.org/10.1136/thx.2003.011866] [PMID: 15170025]
[49]
Sanak, M.; Gielicz, A.; Bochenek, G.; Kaszuba, M.; Niżankowska-Mogilnicka, E.; A, targeted. eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype. J. Allergy Clin. Immunol., 2011, 127(5), 1141-1147.
[http://dx.doi.org/10.1016/j.jaci.2010.12.1108] [PMID: 21315430]
[50]
Sanak, M.; Gielicz, A.; Nagraba, K.; Kaszuba, M.; Kumik, J.; Szczeklik, A. Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2010, 878(21), 1796-1800.
[http://dx.doi.org/10.1016/j.jchromb.2010.05.012] [PMID: 20627827]
[51]
Mastalerz, L.; Sanak, M.; Kumik, J.; Gawlewicz-Mroczka, A.; Celejewska-Wójcik, N.; Cmiel, A.; Szczeklik, A. Exhaled Eicosanoids following Bronchial Aspirin Challenge in Asthma Patients with and without Aspirin Hypersensitivity: The Pilot Study. J. Allergy (Cairo), 2012, 2012696792
[http://dx.doi.org/10.1155/2012/696792] [PMID: 22291720]
[52]
Milne, G.L.; Gao, B.; Terry, E.S.; Zackert, W.E.; Sanchez, S.C. Measurement of F2- isoprostanes and isofurans using gas chromatography-mass spectrometry. Free Radic. Biol. Med., 2013, 59, 36-44.
[http://dx.doi.org/10.1016/j.freeradbiomed.2012.09.030] [PMID: 23044261]
[53]
Lärstad, M.; Söderling, A.S.; Caidahl, K.; Olin, A.C. Selective quantification of free 3-nitrotyrosine in exhaled breath condensate in asthma using gas chromatography/tandem mass spectrometry. Nitric Oxide, 2005, 13(2), 134-144.
[http://dx.doi.org/10.1016/j.niox.2005.05.009] [PMID: 16006156]
[54]
Tsikas, D.; Duncan, M.W. Mass spectrometry and 3-nitrotyrosine: strategies, controversies, and our current perspective. Mass Spectrom. Rev., 2014, 33(4), 237-276.
[http://dx.doi.org/10.1002/mas.21396] [PMID: 24167057]
[55]
Celio, S.; Troxler, H.; Durka, S.S.; Chládek, J.; Wildhaber, J.H.; Sennhauser, F.H.; Heizmann, C.W.; Moeller, A. Free 3-nitrotyrosine in exhaled breath condensates of children fails as a marker for oxidative stress in stable cystic fibrosis and asthma. Nitric Oxide, 2006, 15(3), 226-232.
[http://dx.doi.org/10.1016/j.niox.2006.06.008] [PMID: 16931075]
[56]
Boots, A.W.; Bos, L.D.; van der Schee, M.P.; van Schooten, F.J.; Sterk, P.J. Exhaled Molecular Fingerprinting in Diagnosis and Monitoring: Validating Volatile Promises. Trends Mol. Med., 2015, 21(10), 633-644.
[http://dx.doi.org/10.1016/j.molmed.2015.08.001] [PMID: 26432020]
[57]
Wang, C.J.; Yang, N.H.; Liou, S.H.; Lee, H.L. Fast quantification of the exhaled breath condensate of oxidative stress 8-iso-prostaglandin F2alpha using on-line solid-phase extraction coupled with liquid chromatography/electrospray ionization mass spectrometry. Talanta, 2010, 82(4), 1434-1438.
[http://dx.doi.org/10.1016/j.talanta.2010.07.015] [PMID: 20801352]
[58]
García-Gómez, D.; Martínez-Lozano Sinues, P.; Barrios-Collado, C.; Vidal-de-Miguel, G.; Gaugg, M.; Zenobi, R. Identification of 2-alkenals, 4-hydroxy-2-alkenals, and 4-hydroxy-2,6-alkadienals in exhaled breath condensate by UHPLC-HRMS and in breath by real-time HRMS. Anal. Chem., 2015, 87(5), 3087-3093.
[http://dx.doi.org/10.1021/ac504796p] [PMID: 25646646]
[59]
Montuschi, P.; Santini, G.; Valente, S.; Mondino, C.; Macagno, F.; Cattani, P.; Zini, G.; Mores, N. Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2014, 964, 12-25.
[http://dx.doi.org/10.1016/j.jchromb.2014.02.059] [PMID: 24656639]
[60]
Rosa, M.J.; Yan, B.; Chillrud, S.N.; Acosta, L.M.; Divjan, A.; Jacobson, J.S.; Miller, R.L.; Goldstein, I.F.; Perzanowski, M.S. Domestic airborne black carbon levels and 8-isoprostane in exhaled breath condensate among children in New York City. Environ. Res., 2014, 135, 105-110.
[http://dx.doi.org/10.1016/j.envres.2014.09.003] [PMID: 25262082]
[61]
Pelclová, D.; Fenclová, Z.; Vlcková, S.; Lebedová, J.; Syslová, K.; Pecha, O.; Belácek, J.; Navrátil, T.; Kuzma, M.; Kacer, P. Leukotrienes B4, C4, D4 and E4 in the exhaled breath condensate (EBC), blood and urine in patients with pneumoconiosis. Ind. Health, 2012, 50(4), 299-306.
[http://dx.doi.org/10.2486/indhealth.MS1274] [PMID: 22785421]
[62]
Larsson, P.; Bake, B.; Wallin, A.; Hammar, O.; Almstrand, A.C.; Lärstad, M.; Ljungström, E.; Mirgorodskaya, E.; Olin, A.C. The effect of exhalation flow on endogenous particle emission and phospholipid composition. Respir. Physiol. Neurobiol., 2017, 243, 39-46.
[http://dx.doi.org/10.1016/j.resp.2017.05.003] [PMID: 28502893]
[63]
Montesi, S.B.; Mathai, S.K.; Brenner, L.N.; Gorshkova, I.A.; Berdyshev, E.V.; Tager, A.M.; Shea, B.S. Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis. BMC Pulm. Med., 2014, 14, 5.
[http://dx.doi.org/10.1186/1471-2466-14-5] [PMID: 24468008]
[64]
Monge, M.E.; Pérez, J.J.; Dwivedi, P.; Zhou, M.; McCarty, N.A.; Stecenko, A.A.; Fernández, F.M. Ion mobility and liquid chromatography/mass spectrometry strategies for exhaled breath condensate glucose quantitation in cystic fibrosis studies. Rapid Commun. Mass Spectrom., 2013, 27(20), 2263-2271.
[http://dx.doi.org/10.1002/rcm.6683] [PMID: 24019192]
[65]
Lucca, F.; Da Dalt, L.; Ros, M.; Gucciardi, A.; Pirillo, P.; Naturale, M.; Perilongo, G.; Giordano, G.; Baraldi, E. Asymmetric dimethylarginine and related metabolites in exhaled breath condensate of children with cystic fibrosis. Clin. Respir. J., 2016.
[PMID: 27216780]
[66]
van der Sluijs, K.F.; van de Pol, M.A.; Kulik, W.; Dijkhuis, A.; Smids, B.S.; van Eijk, H.W.; Karlas, J.A.; Molenkamp, R.; Wolthers, K.C.; Johnston, S.L.; van der Zee, J.S.; Sterk, P.J.; Lutter, R. Systemic tryptophan and kynurenine catabolite levels relate to severity of rhinovirus-induced asthma exacerbation: a prospective study with a parallel-group design. Thorax, 2013, 68(12), 1122-1130.
[http://dx.doi.org/10.1136/thoraxjnl-2013-203728] [PMID: 23882022]
[67]
Patel, K.; Davis, S.D.; Johnson, R.; Esther, C.R., Jr Exhaled breath condensate purines correlate with lung function in infants and preschoolers. Pediatr. Pulmonol., 2013, 48(2), 182-187.
[http://dx.doi.org/10.1002/ppul.22573] [PMID: 22615171]
[68]
Esther, C.R., Jr; Olsen, B.M.; Lin, F.C.; Fine, J.; Boucher, R.C. Exhaled breath condensate adenosine tracks lung function changes in cystic fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol., 2013, 304(7), L504-L509.
[http://dx.doi.org/10.1152/ajplung.00344.2012] [PMID: 23355385]
[69]
Rodriguez-Aller, M.; Gurny, R.; Veuthey, J.L.; Guillarme, D. Coupling ultra high-pressure liquid chromatography with mass spectrometry: constraints and possible applications. J. Chromatogr. A, 2013, 1292, 2-18.
[http://dx.doi.org/10.1016/j.chroma.2012.09.061] [PMID: 23062879]
[70]
Fumagalli, M.; Ferrari, F.; Luisetti, M.; Stolk, J.; Hiemstra, P.S.; Capuano, D.; Viglio, S.; Fregonese, L.; Cerveri, I.; Corana, F.; Tinelli, C.; Iadarola, P. Profiling the proteome of exhaled breath condensate in healthy smokers and COPD patients by LC-MS/MS. Int. J. Mol. Sci., 2012, 13(11), 13894-13910.
[http://dx.doi.org/10.3390/ijms131113894] [PMID: 23203040]
[71]
Muccilli, V.; Saletti, R.; Cunsolo, V.; Ho, J.; Gili, E.; Conte, E.; Sichili, S.; Vancheri, C.; Foti, S. Protein profile of exhaled breath condensate determined by high resolution mass spectrometry. J. Pharm. Biomed. Anal., 2015, 105, 134-149.
[http://dx.doi.org/10.1016/j.jpba.2014.11.050] [PMID: 25555262]
[72]
Kononikhin, A.S.; Ryndin, A.Y.; Starodubtseva, N.L.; Chagovets, V.V.; Burov, A.A.; Bugrova, A.E.; Kostyukevich, Y.I.; Popov, I.A.; Frankevich, V.E.; Ionov, O.V.; Zubkov, V.V.; Nikolaev, E.N. Studying the Proteomic Composition of Expired Air Condensate in Newborns on Breathing Support. Bull. Exp. Biol. Med., 2016, 160(6), 861-863.
[http://dx.doi.org/10.1007/s10517-016-3327-0] [PMID: 27165072]
[73]
Conrad, D.H.; Goyette, J.; Thomas, P.S. Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening. J. Gen. Intern. Med., 2008, 23(Suppl. 1), 78-84.
[http://dx.doi.org/10.1007/s11606-007-0411-1] [PMID: 18095050]
[74]
Bloemen, K.; Van Den Heuvel, R.; Govarts, E.; Hooyberghs, J.; Nelen, V.; Witters, E.; Desager, K.; Schoeters, G. A new approach to study exhaled proteins as potential biomarkers for asthma. Clin. Exp. Allergy, 2011, 41(3), 346-356.
[http://dx.doi.org/10.1111/j.1365-2222.2010.03638.x] [PMID: 21105917]
[75]
Liang, Y.; Yeligar, S.M.; Brown, L.A. Exhaled breath condensate: a promising source for biomarkers of lung disease. ScientificWorldJournal, 2012, 2012217518
[http://dx.doi.org/10.1100/2012/217518] [PMID: 23365513]
[76]
Wold, S.; Sjostrom, M.; Eriksson, L. PLS-regression: a basic tool of chemometrics. Chemom. Intell. Lab. Syst., 2001, 58, 109-130.
[http://dx.doi.org/10.1016/S0169-7439(01)00155-1]
[77]
Rinnan, A.; Munck, L. Significance of the structure of data in partial least squares regression predictions involving both natural and human experimental design. J. Chemometr., 2012, 26, 487-495.
[http://dx.doi.org/10.1002/cem.2438]
[78]
Trygg, J.; Wold, S. Orthogonal projections to latent structures (O-PLS). J. Chemometr., 2002, 16, 119-128.
[http://dx.doi.org/10.1002/cem.695]
[79]
Trygg, J.; Wold, S. O2-PLS, a two-block (X-Y) latent variable regression (LVR) method with an integral OSC filter. J. Chemometr., 2003, 17, 53-64.
[http://dx.doi.org/10.1002/cem.775]
[80]
Stocchero, M.; Paris, D. Post-transformation of PLS2 (ptPLS2) by orthogonal matrix: a new approach for generating predictive and orthogonal latent variables. J. Chemometr., 2016, 30, 242-251.
[http://dx.doi.org/10.1002/cem.2780]
[81]
Spraul, M.; Neidig, P.; Klauck, U.; Kessler, P.; Holmes, E.; Nicholson, J.K.; Sweatman, B.C.; Salman, S.R.; Farrant, R.D.; Rahr, E. Automatic reduction of NMR spectroscopic data for statistical and pattern recognition classification of samples. J. Pharm. Biomed. Anal., 1994, 12(10), 1215-1225.
[http://dx.doi.org/10.1016/0731-7085(94)00073-5] [PMID: 7841215]
[82]
Castillo, S.; Gopalacharyulu, P.; Yetukuri, L.; Oresic, M. Algorithms and tools for the preprocessing of LC-MS metabolomics data. Chemom. Intell. Lab. Syst., 2011, 108, 23-32.
[http://dx.doi.org/10.1016/j.chemolab.2011.03.010]
[83]
Goodacre, R.; Broadhurst, D.; Smilde, A.K.; Kristal, B.S.; Baker, J.D.; Beger, R.; Bessant, C.; Connor, S.; Calmani, G.; Craig, A. Proposed minimum reporting standards for data analysis in metabolomics. Metabolomics, 2007, 3, 231-241.
[http://dx.doi.org/10.1007/s11306-007-0081-3]
[84]
Lange, E.; Tautenhahn, R.; Neumann, S.; Gröpl, C. Critical assessment of alignment procedures for LC-MS proteomics and metabolomics measurements. BMC Bioinformatics, 2008, 9, 375.
[http://dx.doi.org/10.1186/1471-2105-9-375] [PMID: 18793413]
[85]
Katajamaa, M.; Oresic, M. Data processing for mass spectrometry-based metabolomics. J. Chromatogr. A, 2007, 1158(1-2), 318-328.
[http://dx.doi.org/10.1016/j.chroma.2007.04.021] [PMID: 17466315]
[86]
Pfeuffer, J.; Sachsenberg, T.; Alka, O.; Walzer, M.; Fillbrunn, A.; Nilse, L.; Schilling, O.; Reinert, K.; Kohlbacher, O.; Open, M.S.; Open, M.S. OpenMS - A platform for reproducible analysis of mass spectrometry data. J. Biotechnol., 2017, 261, 142-148.
[http://dx.doi.org/10.1016/j.jbiotec.2017.05.016] [PMID: 28559010]
[87]
Vu, T.N.; Laukens, K. Getting your peaks in line: a review of alignment methods for NMR spectral data. Metabolites, 2013, 3(2), 259-276.
[http://dx.doi.org/10.3390/metabo3020259] [PMID: 24957991]
[88]
Forshed, J.; Torgrip, R.J.; Aberg, K.M.; Karlberg, B.; Lindberg, J.; Jacobsson, S.P. A comparison of methods for alignment of NMR peaks in the context of cluster analysis. J. Pharm. Biomed. Anal., 2005, 38(5), 824-832.
[http://dx.doi.org/10.1016/j.jpba.2005.01.042] [PMID: 16087044]
[89]
van den Berg, R.A.; Hoefsloot, H.C.; Westerhuis, J.A.; Smilde, A.K.; van der Werf, M.J. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics, 2006, 7, 142.
[http://dx.doi.org/10.1186/1471-2164-7-142] [PMID: 16762068]
[90]
Craig, A.; Cloarec, O.; Holmes, E.; Nicholson, J.K.; Lindon, J.C. Scaling and normalization effects in NMR spectroscopic metabonomic data sets. Anal. Chem., 2006, 78(7), 2262-2267.
[http://dx.doi.org/10.1021/ac0519312] [PMID: 16579606]
[91]
Szymańska, E.; Saccenti, E.; Smilde, A.K.; Westerhuis, J.A. Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies. Metabolomics, 2012, 8(Suppl. 1), 3-16.
[http://dx.doi.org/10.1007/s11306-011-0330-3] [PMID: 22593721]
[92]
Westerhuis, J.A.; Hoefsloot, H.C.J.; Smit, S.; Vis, D.J.; Smilde, A.K.; van Velzen, E.J.J.; van Duijnhoven, J.P.M.; van Dorsten, F.A. Assessment of PLSDA cross validation. Metabolomics, 2008, 4, 81-89.
[http://dx.doi.org/10.1007/s11306-007-0099-6]
[93]
Bush, A.; Fleming, L. Phenotypes of refractory/severe asthma. Paediatr. Respir. Rev., 2011, 12(3), 177-181.
[http://dx.doi.org/10.1016/j.prrv.2011.01.003] [PMID: 21722846]
[94]
Carraro, S.; Rezzi, S.; Reniero, F.; Héberger, K.; Giordano, G.; Zanconato, S.; Guillou, C.; Baraldi, E. Metabolomics applied to exhaled breath condensate in childhood asthma. Am. J. Respir. Crit. Care Med., 2007, 175(10), 986-990.
[http://dx.doi.org/10.1164/rccm.200606-769OC] [PMID: 17303796]
[95]
Maniscalco, M.; Motta, A. Biomarkers in allergic asthma: Which matrix should we use? Clin. Exp. Allergy, 2017, 47(8), 1097-1098.
[http://dx.doi.org/10.1111/cea.12978] [PMID: 28703932]
[96]
Bertini, I.; Luchinat, C.; Miniati, M.; Monti, S.; Tenori, L. Phenotyping COPD by H-1 NMR metabolomics of exhaled breath condensate. Metabolomics, 2014, 10, 302-311.
[http://dx.doi.org/10.1007/s11306-013-0572-3]
[97]
Airoldi, C.; Ciaramelli, C.; Fumagalli, M.; Bussei, R.; Mazzoni, V.; Viglio, S.; Iadarola, P.; Stolk, J. 1H NMR To Explore the Metabolome of Exhaled Breath Condensate in α1-Antitrypsin Deficient Patients: A Pilot Study. J. Proteome Res., 2016, 15(12), 4569-4578.
[http://dx.doi.org/10.1021/acs.jproteome.6b00648] [PMID: 27646345]
[98]
de Laurentiis, G.; Paris, D.; Melck, D.; Montuschi, P.; Maniscalco, M.; Bianco, A.; Sofia, M.; Motta, A. Separating smoking-related diseases using NMR-based metabolomics of exhaled breath condensate. J. Proteome Res., 2013, 12(3), 1502-1511.
[http://dx.doi.org/10.1021/pr301171p] [PMID: 23360153]
[99]
Maniscalco, M.; Paris, D.; Melck, D.J.; Molino, A.; Carone, M.; Ruggeri, P.; Caramori, G.; Motta, A. Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study. Eur. Respir. J., 2018, 51(3) 1701825
[http://dx.doi.org/10.1183/13993003.01825-2017] [PMID: 29348154]
[100]
Maniscalco, M.; Motta, A. Clinical and Inflammatory Phenotyping: Can Electronic Nose and NMR-based Metabolomics Work at the Bedside? Arch. Med. Res, 2018, S0188-4409(18), 30096.
[101]
Montuschi, P.; Paris, D.; Montella, S.; Melck, D.; Mirra, V.; Santini, G.; Mores, N.; Montemitro, E.; Majo, F.; Lucidi, V.; Bush, A.; Motta, A.; Santamaria, F. Nuclear magnetic resonance-based metabolomics discriminates primary ciliary dyskinesia from cystic fibrosis. Am. J. Respir. Crit. Care Med., 2014, 190(2), 229-233.
[http://dx.doi.org/10.1164/rccm.201402-0249LE] [PMID: 25025356]
[102]
Montuschi, P.; Paris, D.; Melck, D.; Lucidi, V.; Ciabattoni, G.; Raia, V.; Calabrese, C.; Bush, A.; Barnes, P.J.; Motta, A. NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis. Thorax, 2012, 67(3), 222-228.
[http://dx.doi.org/10.1136/thoraxjnl-2011-200072] [PMID: 22106016]
[103]
Ibrahim, B.; Marsden, P.; Smith, J.A.; Custovic, A.; Nilsson, M.; Fowler, S.J. Breath metabolomic profiling by nuclear magnetic resonance spectroscopy in asthma. Allergy, 2013, 68(8), 1050-1056.
[http://dx.doi.org/10.1111/all.12211] [PMID: 23888905]
[104]
Sinha, A.; Desiraju, K.; Aggarwal, K.; Kutum, R.; Roy, S.; Lodha, R.; Kabra, S.K.; Ghosh, B.; Sethi, T.; Agrawal, A. Exhaled breath condensate metabolome clusters for endotype discovery in asthma. J. Transl. Med., 2017, 15(1), 262.
[http://dx.doi.org/10.1186/s12967-017-1365-7] [PMID: 29273025]
[105]
Paris, D.; Maniscalco, M.; Melck, D.; D’Amato, M.; Sorrentino, N.; Zedda, A.; Sofia, M.; Motta, A. Inflammatory metabolites in exhaled breath condensate characterize the obese respiratory phenotype. Metabolomics, 2015, 11, 1934-1939.
[http://dx.doi.org/10.1007/s11306-015-0805-8]
[106]
Maniscalco, M.; Paris, D.; Melck, D.J.; D’Amato, M.; Zedda, A.; Sofia, M.; Stellato, C.; Motta, A. Coexistence of obesity and asthma determines a distinct respiratory metabolic phenotype. J. Allergy Clin. Immunol., 2017, 139(5), 1536-1547.e5.
[http://dx.doi.org/10.1016/j.jaci.2016.08.038] [PMID: 27746236]
[107]
Kilk, K.; Aug, A.; Ottas, A.; Soomets, U.; Altraja, S.; Altraja, A. Phenotyping of Chronic Obstructive Pulmonary Disease Based on the Integration of Metabolomes and Clinical Characteristics. Int. J. Mol. Sci., 2018, 19(3)E666
[http://dx.doi.org/10.3390/ijms19030666] [PMID: 29495451]
[108]
Rindlisbacher, B.; Strebel, C.; Guler, S.; Kollár, A.; Geiser, T.; Martin Fiedler, G.; Benedikt Leichtle, A.; Bovet, C.; Funke-Chambour, M. Exhaled breath condensate as a potential biomarker tool for idiopathic pulmonary fibrosis-a pilot study. J. Breath Res., 2017, 12(1)016003
[http://dx.doi.org/10.1088/1752-7163/aa840a] [PMID: 28775244]
[109]
Peralbo-Molina, A.; Calderón-Santiago, M.; Priego-Capote, F.; Jurado-Gámez, B.; Luque de Castro, M.D. Identification of metabolomics panels for potential lung cancer screening by analysis of exhaled breath condensate. J. Breath Res., 2016, 10(2)026002
[http://dx.doi.org/10.1088/1752-7155/10/2/026002] [PMID: 27007686]
[110]
Zang, X.; Pérez, J.J.; Jones, C.M.; Monge, M.E.; McCarty, N.A.; Stecenko, A.A.; Fernández, F.M. Comparison of Ambient and Atmospheric Pressure Ion Sources for Cystic Fibrosis Exhaled Breath Condensate Ion Mobility-Mass Spectrometry Metabolomics. J. Am. Soc. Mass Spectrom., 2017, 28(8), 1489-1496.
[http://dx.doi.org/10.1007/s13361-017-1660-9] [PMID: 28364225]
[111]
Carraro, S; Giordano, G; Pirillo, P; Maretti, M; Reniero, F; Cogo, PE; Perilongo, G; Stocchero, M; Baraldi, E Airway metabolic anomalies in adolescents with bronchopulmonary dysplasia: new insights from the metabolomic approach J. Pediatr, 2015, 166(2), 234-239. e231.
[http://dx.doi.org/10.1016/j.jpeds.2014.08.049]
[112]
Fermier, B.; Blasco, H.; Godat, E.; Bocca, C.; Moënne-Loccoz, J.; Emond, P.; Andres, C.R.; Laffon, M.; Ferrandière, M. Specific Metabolome Profile of Exhaled Breath Condensate in Patients with Shock and Respiratory Failure: A Pilot Study. Metabolites, 2016, 6(3), 6.
[http://dx.doi.org/10.3390/metabo6030026] [PMID: 27598216]
[113]
Zang, X.; Monge, M.E.; McCarty, N.A.; Stecenko, A.A.; Fernández, F.M. Feasibility of Early Detection of Cystic Fibrosis Acute Pulmonary Exacerbations by Exhaled Breath Condensate Metabolomics: A Pilot Study. J. Proteome Res., 2017, 16(2), 550-558.
[http://dx.doi.org/10.1021/acs.jproteome.6b00675] [PMID: 28152602]
[114]
Carraro, S.; Giordano, G.; Reniero, F.; Carpi, D.; Stocchero, M.; Sterk, P.J.; Baraldi, E. Asthma severity in childhood and metabolomic profiling of breath condensate. Allergy, 2013, 68(1), 110-117.
[http://dx.doi.org/10.1111/all.12063] [PMID: 23157191]
[115]
Kononikhin, A.S.; Starodubtseva, N.L.; Chagovets, V.V.; Ryndin, A.Y.; Burov, A.A.; Popov, I.A.; Bugrova, A.E.; Dautov, R.A.; Tokareva, A.O.; Podurovskaya, Y.L.; Ionov, O.V.; Frankevich, V.E.; Nikolaev, E.N.; Sukhikh, G.T. Exhaled breath condensate analysis from intubated newborns by nano-HPLC coupled to high resolution MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2017, 1047, 97-105.
[http://dx.doi.org/10.1016/j.jchromb.2016.12.036] [PMID: 28040456]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy